Anyone who has invested their time in creating improved outcomes for patients becomes familiar with a kind of balancing act.
You must be committed to the science and precision involved in diagnosis and therapy – the research, the development, the trials, the care plan. You must also be devoted to the art of the therapy – the patient’s well-being, the expectations, the lives impacted.
After all, the patients we care for are…people. And so, anyone who has invested time in creating actual, improved outcomes knows: it’s a balance.
Our guest on this episode of Rare Voices is an example of what happens with science meets art. He is a master at understanding how to balance what seem like two competing ideas. Dave Penake, CEO of Saol Therapeutics, combines his training as an engineer and systems designer with his passion for serving patients with rare and orphan diseases.
Previous to Saol, Dave served as Vice President, Commercial Operations at Corcept Therapeutics and held roles of increasing responsibility at Genentech. In addition to his experience in biotechnology and pharmaceuticals, Dave has designed and launched devices and has experience in a number of different technologies.
As you listen to our conversation, be prepared to be provoked by big questions, the kind that will check your balance and set you on a new course — one where you can really put the patient first.
More About Dave
David Penake has been CEO of Saol Therapeutics since April 2016. He was previously Vice President, Commercial Operations at Corcept Therapeutics and held roles of increasing responsibility at Genentech in both their technical and commercially focused organizations. In addition to his experience in biotechnology and pharmaceuticals, Mr. Penake has designed and launched devices and has experience in a number of different technologies.
Throughout his career, Mr. Penake has been instrumental in working with large distributors in all major pharmaceutical channels in the United States. In addition to his commercial experience, Mr. Penake holds seven patents ranging from pharmaceutical formulations to medical devices and has a number of patents currently under application. He holds a Bachelor of Science in Materials Science and Engineering from Northwestern University, a Masters in Business Administration, a Masters in Materials Science and Engineering from the Massachusetts Institute of Technology, and has completed post-graduate study and research at Stanford University and Harvard Medical School.
Westpoint Instrumental by Sun Shapes